パップテストの世界市場

パップテストの世界市場は2030年までに185億米ドルに達する見込み

2024年に98億米ドルと推定されるパップテストの世界市場は、2024年から2030年にかけてCAGR 11.1%で成長し、2030年には185億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである液体ベースのテストは、CAGR 12.2%を記録し、分析期間終了までに135億米ドルに達すると予測されます。従来型検査分野の成長率は、分析期間中CAGR 8.5%と推定されます。

米国市場は27億米ドル、中国はCAGR15.3％で成長すると予測

米国のパップテスト市場は、2024年に27億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに39億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは15.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.0％と9.9％と予測されています。欧州では、ドイツがCAGR 8.8%で成長すると予測されています。

世界のパップテスト市場- 主要動向と促進要因のまとめ

代替医療の台頭にもかかわらず、子宮頸がん検診の要が依然としてパップテストである理由とは？

パパニコロウ検査は、一般的にパップテストまたはパップスメアとして知られ、世界中で子宮頸がん検診の基本的なツールであり続けています。20世紀半ばに開発されたこの細胞診検査は、子宮頸部の前がん細胞やがん細胞を検出し、浸潤がんが発生する前に早期診断と介入を可能にします。HPV DNA検査や液体ベースの細胞診の使用が増加しているにもかかわらず、パップテストは、その幅広い利用可能性、費用対効果、および多くの国で子宮頸がんの発生率と死亡率を大幅に減少させた確立された臨床ガイドラインにより、依然として不可欠です。

パップテストは通常、21歳から65歳の女性に推奨され、患者の病歴や共同検査の実施状況にもよるが、3年から5年ごとに実施されることが多いです。パップテストの永続的な意義は、非定型扁平上皮細胞、腺管変化、感染症など、高リスクHPV株以外のさまざまな異常を検出できることにあります。さらに、パップスメアの結果は即座に対処可能であり、コルポスコピー、生検、ループ電気外科的切除（LEEP）などのフォローアップ処置の指針となります。このように標準的な婦人科診療に組み込まれることで、臨床医の高いコンプライアンスと慣れが保証されます。

HPVワクチン接種プログラムが拡大しても、ワクチン接種範囲の制限、HPV関連疾患の潜伏期間、およびワクチン以外のHPV株の存在により、子宮頸部スクリーニングの必要性は持続しています。パップテストは、感度と特異度を向上させるため、HPV検査と併用するデュアルスクリーニング方式が採用されるようになってきています。先進的な診断法に容易にアクセスできない可能性のある中低所得国（LMICs）では、パップテストは依然として最も実現可能でスケーラブルなスクリーニング法であり、特に視触診やモバイルヘルス（mヘルス）ソリューションと組み合わせた場合に有効です。

PAP検査における診断技術と採取方法はどのように進化しているか？

PAP検査における技術革新は、検査の精度と利便性の両方を高めています。主な進歩の1つは、従来の塗抹法から液体ベース細胞診（LBC）への移行です。LBCでは、子宮頸部細胞をスライドに直接塗抹するのではなく、液体培地のバイアルに保存します。LBCは、より均一な細胞分布、不明瞭なアーチファクト（血液や粘液など）の減少、HPV、クラミジア、淋菌の診断を含む同一サンプルからの追加検査の可能性を可能にします。

デジタル細胞診と人工知能（AI）支援分析は、パップテストの解釈にも変化をもたらしています。画像認識ソフトウェアと機械学習モデルは、細胞検査士と病理医によるレビューのために異常細胞にフラグを立てるスライドの事前スクリーニングにますます使用されるようになっています。この二重レビューモデルはヒューマンエラーを減らし、ラボのワークフローを合理化します。ホロジックやロシュ・ダイアグノスティックスのような企業は、大規模な都市センターや十分なサービスを受けていない地域の両方で、より迅速でスケーラブルな子宮頸がん検診の需要に応えるため、AI主導の細胞診プラットフォームに積極的に投資しています。

セルフサンプリング技術もまた、アクセスと参加率の向上を目指した重要な開発です。女性は、診療所、薬局、または宅配で配布されるキットを使用して、子宮頸部または膣のサンプルを自分で採取することができます。セルフサンプリングは現在、HPV検査に関連するのが一般的ですが、現在進行中の試験では、LBC対応のパップテストへの統合が検討されています。このような方法は、文化的、物流的、あるいはインフラ的な障壁によって診療所への受診が制限されている農村部や保守的な地域の女性に到達するために極めて重要です。

市場力学を形成している地域保健イニシアチブと人口動態要因は何か？

パップテスト市場は、地域の検診プログラム、政府の政策、公衆衛生への働きかけと密接に結びついています。北米と西欧では、組織的な検診プログラムと保険適用が、高い検査受診率と子宮頸がん罹患率の低下に寄与しています。米国予防サービス専門委員会（USPSTF）と国民保健サービス（NHS）は、女性の定期健康診断の一環としてパップテストを推進し続けており、30～65歳の女性に対してはHPV共同検査と組み合わせて実施することが多いです。

アジア太平洋地域は複雑な様相を呈しています。日本や韓国のような国々は、体系化された検診プログラムを実施しているが、国民の認識や社会的偏見に関する課題に直面しています。インド、インドネシア、サハラ以南のアフリカの一部では、不十分なインフラ、訓練を受けた人材の不足、一貫性のないフォローアップの仕組みのために、パップテストのカバー率が低いです。しかし、WHOの「子宮頸がん撲滅のための世界戦略」や、PATHやJhpiegoのようなNGOが支援するイニシアティブが、移動式検診ユニット、AI診断、地域保健ワーカーの関与を利用して、このギャップを埋めようとしています。

人口動態的には、市場は女性の健康に対する意識の高まり、新興市場における中流階級の人口増加、リプロダクティブ・ヘルス（性と生殖に関する健康）監視の拡大が必要となる出産遅延動向の影響を受けています。さらに、民間医療サービスや遠隔医療相談の導入が進んでいるため、特にスマートフォンが普及しデジタルヘルス・インフラが整備された都市部では、パップテストによる予約、診察、結果提供がより合理化されています。

パップテスト市場の今後の主な成長促進要因は？

世界のパップテスト市場の成長の原動力は、子宮頸がん検診に対する意識の高まり、細胞診の技術向上、政府主導の予防医療プログラム、HPVワクチン接種率の継続的な格差です。代替の分子診断薬が利用可能であるにもかかわらず、パップテストは、特にヘルスケア予算や検査インフラが限られているLMICsにおいて、最も費用対効果が高く、利用しやすいスクリーニング手段であり続けています。

子宮頸がんの負担が増大していることから、特に十分な医療が行き届いていない地域では、定期検診へのアクセスを拡大するための世界の取り組みが再開されています。WHOの90-70-90戦略（90％の女児がワクチン接種を受け、70％の女性が検診を受け、90％の女性が治療を受ける）は、HPV検査やワクチン接種キャンペーンと並行して拡大する移行期の技術として、PAP検査の役割を明確に認識しています。さらに、移動検査室、地域保健アウトリーチプログラム、官民パートナーシップの存在感の拡大により、以前は十分なサービスを受けられなかった地域へのPAP検査の浸透が進んでいます。

供給側では、採取装置や染色試薬からデジタル病理プラットフォームやクラウドベースの結果配信システムまで、バリューチェーン全体で革新的な取り組みを行っている診断薬メーカーが市場を支えています。ホロジック、BD、ロシュ、シージーンなどの業界大手は、検査スループットを向上させ、技師の作業負担を最小限に抑える次世代プラットフォームに投資しています。子宮頸がんは依然として世界の女性、特にLMICsにおけるがん死亡原因の上位を占めているため、パップテストは世界のスクリーニングパラダイムの中心的な要素であり続け、新しい技術とともに進化しながら、最前線の診断ツールとしての役割を維持します。

セグメント

方法（液体ベース検査、従来型検査）、検査タイプ（パップスメア検査、HPV一次スクリーニング、共同検査、HPVフォローアップ検査）、用途（子宮頸がんスクリーニング用途、膣がんスクリーニング用途、その他用途）、最終用途（調査最終用途、診断センター最終用途、病院・診療所最終用途、その他最終用途）

調査対象企業の例

• Abbott Laboratories
• Arbor Vita Corporation
• AstraZeneca plc
• Beckman Coulter
• Becton, Dickinson & Company（BD）
• bioMerieux SA
• Bio-Rad Laboratories
• Cardinal Health
• Cardinal Health（Lab Supplies）
• CellNetix Pathology & Laboratories
• Cepheid
• CooperSurgical
• CooperSurgical（Cytology kits）
• Danaher Corporation
• DiaSys
• EKF Diagnostics
• F. Hoffmann-La Roche AG（Roche）
• Femasys, Inc.
• Fujirebio Diagnostics, Inc.
• Hologic Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家からキュレートされたコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Pap Test Market to Reach US$18.5 Billion by 2030

The global market for Pap Test estimated at US$9.8 Billion in the year 2024, is expected to reach US$18.5 Billion by 2030, growing at a CAGR of 11.1% over the analysis period 2024-2030. Liquid-based Test, one of the segments analyzed in the report, is expected to record a 12.2% CAGR and reach US$13.5 Billion by the end of the analysis period. Growth in the Conventional-based Test segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.7 Billion While China is Forecast to Grow at 15.3% CAGR

The Pap Test market in the U.S. is estimated at US$2.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.9 Billion by the year 2030 trailing a CAGR of 15.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.0% and 9.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 8.8% CAGR.

Global Pap Test Market - Key Trends & Drivers Summarized

Why Is the Pap Test Still the Cornerstone of Cervical Cancer Screening Despite Rising Alternatives?

The Papanicolaou test, commonly known as the Pap test or Pap smear, continues to be a fundamental tool in cervical cancer screening worldwide. Developed in the mid-20th century, this cytological test detects precancerous and cancerous cells on the cervix, enabling early diagnosis and intervention before invasive cancer develops. Despite the growing use of HPV DNA testing and liquid-based cytology, Pap testing remains indispensable due to its wide accessibility, cost-effectiveness, and established clinical guidelines that have significantly reduced cervical cancer incidence and mortality in many countries.

Pap tests are typically recommended for women aged 21 to 65 and are often conducted every three to five years, depending on patient history and co-testing practices. The enduring relevance of Pap tests lies in their capacity to detect a range of abnormalities beyond high-risk HPV strains, including atypical squamous cells, glandular changes, and infections. Moreover, Pap smear results are immediately actionable, guiding follow-up procedures such as colposcopy, biopsy, or loop electrosurgical excision (LEEP). This integration into standard gynecological care ensures high compliance and familiarity among clinicians.

Even as HPV vaccination programs expand, the need for cervical screening persists due to limited vaccine coverage, latency of HPV-related disease progression, and the presence of non-vaccine HPV strains. Pap tests are increasingly being employed in tandem with HPV testing in a dual-screening approach, improving sensitivity and specificity. In low- and middle-income countries (LMICs), where advanced diagnostics may not be readily accessible, Pap tests remain the most feasible and scalable screening method-especially when paired with visual inspection and mobile health (mHealth) solutions.

How Are Diagnostic Technologies and Collection Methods Evolving in Pap Testing?

Technological innovation in Pap testing is enhancing both the accuracy and convenience of the procedure. One major advancement is the shift from conventional smear techniques to liquid-based cytology (LBC), wherein cervical cells are preserved in a vial of liquid medium rather than being smeared directly onto a slide. LBC allows for more uniform cell distribution, fewer obscuring artifacts (such as blood or mucus), and the potential for additional testing from the same sample-including HPV, chlamydia, and gonorrhea diagnostics.

Digital cytology and artificial intelligence (AI)-assisted analysis are also transforming Pap test interpretation. Image recognition software and machine learning models are increasingly used to pre-screen slides, flagging abnormal cells for review by cytotechnologists and pathologists. This dual-review model reduces human error and streamlines laboratory workflows. Companies like Hologic and Roche Diagnostics are actively investing in AI-driven cytology platforms to meet the demand for faster, scalable cervical cancer screening in both high-volume urban centers and underserved regions.

Self-sampling techniques are another significant development aimed at improving access and participation rates. Women can collect cervical or vaginal samples themselves using kits distributed via clinics, pharmacies, or home delivery. Although self-sampling is currently more commonly associated with HPV testing, ongoing trials are exploring its integration into LBC-compatible Pap tests. Such methods are crucial for reaching women in rural or conservative areas where cultural, logistical, or infrastructural barriers limit clinic visits.

What Regional Health Initiatives and Demographic Factors Are Shaping Market Dynamics?

The Pap test market is intricately tied to regional screening programs, government policies, and public health outreach. In North America and Western Europe, organized screening programs and insurance coverage have contributed to high test uptake and declining cervical cancer rates. The U.S. Preventive Services Task Force (USPSTF) and the National Health Service (NHS) continue to promote Pap testing as part of routine women’s health visits, often in combination with HPV co-testing for women aged 30 to 65.

Asia-Pacific presents a complex landscape. Countries like Japan and South Korea have structured screening programs but face challenges related to public awareness and social stigma. India, Indonesia, and parts of Sub-Saharan Africa have low Pap test coverage due to inadequate infrastructure, shortage of trained personnel, and inconsistent follow-up mechanisms. However, initiatives supported by the WHO’s Global Strategy to Eliminate Cervical Cancer and NGOs like PATH and Jhpiego are working to bridge this gap using mobile screening units, AI diagnostics, and community health worker engagement.

Demographically, the market is influenced by increasing awareness of women’s health, rising middle-class populations in emerging markets, and delayed childbearing trends that necessitate extended reproductive health surveillance. Additionally, the growing adoption of private healthcare services and telehealth consultations is making Pap test booking, consultation, and result delivery more streamlined, particularly in urban areas with smartphone penetration and digital health infrastructure.

What Are the Key Growth Drivers of the Pap Test Market Moving Forward?

The growth in the global Pap test market is driven by increasing awareness of cervical cancer screening, technological improvements in cytology, government-led preventive health programs, and ongoing gaps in HPV vaccine coverage. Despite the availability of alternate molecular diagnostics, the Pap test remains the most cost-effective and accessible screening tool, particularly in LMICs where healthcare budgets and laboratory infrastructure remain limited.

The growing burden of cervical cancer-especially in underserved regions-has led to renewed global efforts to expand access to routine screening. WHO’s 90-70-90 strategy (90% of girls vaccinated, 70% of women screened, and 90% of those treated) explicitly recognizes the role of Pap testing as a transitional technology to be scaled alongside HPV testing and vaccination campaigns. Moreover, the expanding presence of mobile labs, community health outreach programs, and public-private partnerships is enabling greater penetration of Pap testing into previously underserved areas.

On the supply side, the market is supported by diagnostics manufacturers innovating across the value chain-from collection devices and staining reagents to digital pathology platforms and cloud-based result dissemination systems. Industry players such as Hologic, BD, Roche, and Seegene are investing in next-generation platforms that improve test throughput and minimize technician workload. With cervical cancer still among the top causes of cancer death in women worldwide, especially in LMICs, Pap tests will remain a central component of the global screening paradigm, evolving alongside new technologies but retaining their role as a frontline diagnostic tool.

SCOPE OF STUDY:

The report analyzes the Pap Test market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Method (Liquid-based Test, Conventional-based Test); Test Type (Pap Smear Test, Primary HPV Screening, Co-Testing, Follow-Up Test for HPV); Application (Cervical Cancer Screening Application, Vaginal Cancer Screening Application, Other Applications); End-Use (Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Arbor Vita Corporation
• AstraZeneca plc
• Beckman Coulter
• Becton, Dickinson & Company (BD)
• bioMerieux SA
• Bio-Rad Laboratories
• Cardinal Health
• Cardinal Health (Lab Supplies)
• CellNetix Pathology & Laboratories
• Cepheid
• CooperSurgical
• CooperSurgical (Cytology kits)
• Danaher Corporation
• DiaSys
• EKF Diagnostics
• F. Hoffmann-La Roche AG (Roche)
• Femasys, Inc.
• Fujirebio Diagnostics, Inc.
• Hologic Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Pap Test - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Increased Emphasis on Cervical Cancer Screening Drives Global Pap Test Utilization
  • Expansion of Women's Preventive Healthcare Services Throws the Spotlight on Routine Pap Testing
  • Government-Led Screening Programs in Emerging Markets Spur Mass Test Adoption
  • Rising Awareness of HPV-Cervical Cancer Link Strengthens Business Case for Early Detection
  • Integration of Liquid-Based Cytology Methods Enhances Diagnostic Accuracy and Test Adoption
  • Technological Advancements in AI-Driven Cytological Screening Propel Market Modernization
  • Growth in Point-of-Care Testing Infrastructure Expands Access in Rural and Underserved Regions
  • Rising Female Health Consciousness Accelerates Demand for Annual Cervical Screenings
  • Reimbursement Reforms and Policy Incentives Sustain Adoption in Developed Healthcare Markets
  • Increased Use of Co-Testing (Pap + HPV) Drives Comprehensive Cervical Cancer Screening Protocols
  • Expanding Network of Gynecology Clinics and Diagnostic Labs Boosts Test Availability
  • Self-Sampling Devices and Home Test Kits Strengthen Accessibility and Privacy for End-Users
  • HPV Vaccination Campaigns Create New Dialogue Around Follow-Up Screening Practices
  • Digital Health Portals Enhance Test Awareness and Result Management Among Patients
  • Demographic Aging and Preventive Screening Focus Expand Target Cohort for Routine Pap Tests
  • Telehealth Integration Supports Remote Consultations and Encourages Screening Compliance
  • Development of High-Sensitivity Assays Improves Detection Rates and Physician Confidence
  • Global Collaborations for Women's Health Research Support Technological Advancements in Pap Tests
  • Increased Investment in Diagnostic Infrastructure in Africa and Asia Supports Market Growth
  • Healthcare Professional Training and Quality Assurance Programs Drive Test Accuracy and Adoption
  • Data Analytics and Registry Integration Improve Population-Level Monitoring of Screening Efficacy
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Pap Test Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Pap Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Pap Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Pap Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Liquid-based Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Liquid-based Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Liquid-based Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Conventional-based Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Conventional-based Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Conventional-based Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Research Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Hospitals & Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Hospitals & Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Pap Smear Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Pap Smear Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Pap Smear Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Primary HPV Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Primary HPV Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Primary HPV Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Co-Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Co-Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Co-Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Follow-Up Test for HPV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Follow-Up Test for HPV by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Follow-Up Test for HPV by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Cervical Cancer Screening Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Cervical Cancer Screening Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Cervical Cancer Screening Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Vaginal Cancer Screening Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Vaginal Cancer Screening Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Vaginal Cancer Screening Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: USA 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: USA 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: USA 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: Canada 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: Canada 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Canada 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• JAPAN
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Japan 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Japan 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 74: Japan Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Japan 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Japan 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• CHINA
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 80: China Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: China 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 83: China Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: China Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: China 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 86: China Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: China 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: China 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• EUROPE
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Pap Test by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Pap Test by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: Europe 16-Year Perspective for Pap Test by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: Europe 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 98: Europe Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Europe 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• FRANCE
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 107: France Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: France 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 110: France Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: France Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: France 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 113: France Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: France 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: France 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• GERMANY
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: Germany 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 122: Germany Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Germany Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: Germany 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 125: Germany Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Germany 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Germany 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Italy 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 134: Italy Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Italy Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Italy 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 137: Italy Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Italy 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Italy 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 143: UK Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: UK 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 146: UK Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: UK Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: UK 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 149: UK Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: UK 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: UK 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: Spain 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 158: Spain Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Spain Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: Spain 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 161: Spain Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Spain 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Spain 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Russia 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 170: Russia Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Russia Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Russia 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 173: Russia Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Russia 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Russia 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Europe Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Rest of Europe 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Pap Test by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Pap Test by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 16-Year Perspective for Pap Test by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• AUSTRALIA
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Australia 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 209: Australia Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Australia Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Australia 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 212: Australia Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Australia 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Australia 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• INDIA
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 218: India Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: India 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 221: India Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: India Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: India 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 224: India Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: India 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: India 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: South Korea 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 233: South Korea Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: South Korea Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: South Korea 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: South Korea 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: South Korea 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Asia-Pacific Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: Rest of Asia-Pacific 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Pap Test by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Pap Test by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Latin America 16-Year Perspective for Pap Test by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Latin America 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Latin America 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Argentina 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 272: Argentina Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Argentina Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Argentina 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Argentina 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Argentina 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Brazil 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 284: Brazil Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Brazil Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Brazil 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Brazil 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Brazil 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Mexico 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 296: Mexico Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Mexico Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Mexico 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Mexico 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Mexico 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Latin America Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Rest of Latin America 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Pap Test by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Pap Test by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Middle East 16-Year Perspective for Pap Test by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Middle East 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Middle East 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Iran 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 335: Iran Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Iran Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Iran 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 338: Iran Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Iran 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Iran 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Israel 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 347: Israel Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Israel Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Israel 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 350: Israel Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Israel 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Israel 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Saudi Arabia Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Saudi Arabia 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: UAE 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 371: UAE Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: UAE Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: UAE 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 374: UAE Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: UAE 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: UAE 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Rest of Middle East Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: Rest of Middle East 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030
• AFRICA
  • Pap Test Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Pap Test by Method - Liquid-based Test and Conventional-based Test - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Pap Test by Method - Liquid-based Test and Conventional-based Test Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Africa 16-Year Perspective for Pap Test by Method - Percentage Breakdown of Value Sales for Liquid-based Test and Conventional-based Test for the Years 2014, 2025 & 2030
  • TABLE 395: Africa Recent Past, Current & Future Analysis for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Africa Historic Review for Pap Test by End-Use - Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Africa 16-Year Perspective for Pap Test by End-Use - Percentage Breakdown of Value Sales for Research Laboratories End-Use, Diagnostic Centers End-Use, Hospitals & Clinics End-Use and Other End-Uses for the Years 2014, 2025 & 2030
  • TABLE 398: Africa Recent Past, Current & Future Analysis for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for Pap Test by Test Type - Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Africa 16-Year Perspective for Pap Test by Test Type - Percentage Breakdown of Value Sales for Pap Smear Test, Primary HPV Screening, Co-Testing and Follow-Up Test for HPV for the Years 2014, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for Pap Test by Application - Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 403: Africa 16-Year Perspective for Pap Test by Application - Percentage Breakdown of Value Sales for Cervical Cancer Screening Application, Vaginal Cancer Screening Application and Other Applications for the Years 2014, 2025 & 2030

IV. COMPETITION